Cover Image

Guidance for industry M4S, the CTD, safety.

Other Authors:	Center for Drug Evaluation and Research (U.S.), Center for Biologics Evaluation and Research (U.S.), International Conference on Harmonisation.
Format:	Electronic
Language:	English
Published:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, [2001]
Physical Description:	ii, 21 pages : digital, PDF file.
Subjects:	Drug approval -- Government policy -- United States. Clinical trials -- Reporting -- Government policy -- United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS114402

Similar Items

Guidance for industry M4, organization of the CTD
Published: (2001)

Guidance for industry M4Q, the CTD, quality
Published: (2001)

Guidance for industry M4S, the CTD, safety appendices
Published: (2001)

Guidance for industry M4E, the CTD, efficacy
Published: (2001)

Information sheet guidance for institutional review boards and clinical investigators (continuing review after study approval)
Published: (1998)

Guidance for industry providing regulatory submissions in electronic format : human pharmaceutical product applications and related submissions using the eCTD specifications
Published: (2008)

Guidance for clinical trial sponsors on the establishment and operation of clinical trial data monitoring committees
Published: (2001)

NIOSH recommendations for occupational safety and health compendium of policy documents and statements
by: National Institute for Occupational Safety and Health.
Published: (1992)

Reviewer guidance conducting a clinical safety review of a new product application and preparing a report on the review
Published: (2005)

Guidance for industry information request and discipline review letters under the prescription drug user fee act
Published: (2001)

Guidance for industry postmarketing studies and clinical trials, implementation of section 505(o) of the Federal Food, Drug, and Cosmetic Act
Published: (2009)

Guidance for industry E 10 choice of control group and related issues in clinical trials
Published: (2001)

Food safety current and emerging issues influencing public health and trade : U.S. food safety outreach meeting highlights, European Union, Brussels, Belgium; Warsaw, Poland; Prague, Czech Republic; Budapest, Hungary
Published: (2002)

The United States food safety system
Published: (2000)

Guidance for industry E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs, questions and answers
Published: (2008)

Guidance for industry Prescription Drug Marketing Act, donation of prescription drug samples to free clinics
Published: (2006)

Guidance for industry providing regulatory submissions in electronic format, prescription drug advertising and promotional labeling
Published: (2001)

Guidance for industry clinical lactation studies; study design, data analysis, and recommendations for labeling
Published: (2005)

Guidance for industry computerized systems used in clinical trials
Published: (1999)

Guidance for industry reports on the status of postmarketing study commitments : implementation of section 130 of the Food and Drug Administration Modernization Act of 1997
Published: (2006)

Guidance for industry information program on clinical trials for serious or life-threatening diseases and conditions
Published: (2002)

Guidance for industry submitting type V drug master files to the Center for Biologics Evaluation and Research
Published: (2001)

Guidance for industry format and content for the CMC section of an annual report
Published: (1994)

Guidance for industry postmarketing adverse event reporting for medical products and dietary supplements during an influenza pandemic
Published: (2008)

Guidance for industry collection of race and ethnicity data in clinical trials
Published: (2005)

Guidance for industry court decisions, ANDA approvals, and 180-day exclusivity under the Hatch-Waxman amendments to the Federal Food, Drug, and Cosmetic Act
Published: (2000)

Guidance for industry M2 eCTD specification : questions & answers and change requests
Published: (2005)

Structure and content of clinical study reports
Published: (1996)

Report and recommendations of the Clinical Trials Network Work Group
by: National Institute on Drug Abuse. Clinical Trials Network Work Group.
Published: (2003)

Guidance for hospitals, nursing homes and other health care facilities
Published: (2001)

Guidance for industry drug-induced liver injury, premarketing clinical evaluation
Published: (2009)

Guidance for industry E9 statistical principles for clinical trials
Published: (1998)

Guidance for industry exports under the FDA Export Reform and Enhancement Act of 1996
Published: (2007)

Guidance for industry changes to an approved application : biological products, human blood and blood components intended for transfusion or for further manufacture
Published: (2001)

Guidance for industry acceptance of foreign clinical studies
Published: (2001)

Guidance for industry patient-reported outcome measures, use in medical product development to support labeling claims
Published: (2006)

Guidance for industry fast track drug development programs, designation, development and application review
Published: (2004)

Guidance for industry Q8(R2) pharmaceutical development
Published: (2009)

Guidance for industry SPL standard for content of labeling technical Qs & As
Published: (2009)

Guidance for industry bioequivalence recommendations for specific products
Published: (2007)